Our own Alvin Chin, Prostate Cancer Survivor & Advocate, Virginia Prostate Coalition, joins oncologists Howard Scher MD, Donald S. Coffey, PhD, Peter S. Nelson, MD and representatives from research and the Pharma industry for a round table discussion April 23. You can make your voice heard by joining the conference by phone and emailing questions [...]
Today I posted the following on the ACOR Prostate listserv. It was in response to a series of emails that complained 1- That the organizations representing the prostate cancer community were at odds with each other and that there are too many prostate organizations. 2- That the prostate cancer community is disorganized and unable to [...]
The following statement about the recent controversy regarding PSA testing was issued this morning by the thirteen organizations , including Malecare A JOINT STATEMENT FROM AMERICA’S PROSTATE CANCER ADVOCACY, EDUCATION, AND SUPPORT ORGANIZATIONS Since 1993, when the PLCO trial was started, we have awaited the results of this trial with eager anticipation, as have others. [...]
Over the last few days the media has been full of debate about the most recent, contradictory studies that have been released about the efficacy of the PSA as a diagnostic tool for prostate cancer. Normally, I would not write about this issue in this blog since those of us with recurrences and advanced prostate [...]
The FDA has issued an emergency warning that certain adhesive patches (transdermal patches) that deliver medication through the skin have been found to be a risk to patients safety while they undergo a magnetic resonance imaging (MRI). If these problem patches are affixed to the skin while actually undergoing the scan they can cause skin [...]
Why should I participate in a clinical trial? If I participate in a trial I take a risk and probably the trial will fail to prove that there is a better drug or treatment, so why should I put myself at risk with no chance of anyone getting any benefit? This is an excellent question [...]
Marshall Edwards, Inc. (NASDAQ: MSHL) is planning to release preliminary results from a Phase II clinical trial of oral phenoxodiol in patients with early and advanced stage prostate cancer. The results will be presented by the Yale researchers, who were responsible for the study, at the ASCO Genitourinary Cancers Symposium in Orlando, Florida; February 26-28, [...]
Over 15,000 people signed our community’s petition to Make Prostate Cancer a National Priority at . We were ready to deliver the petition to the new Secretary of HHS when Mr. Daschle withdrew from consideration. Now, we await the next Secretary and our new appointment to meet him/her. Until then, we continue to collect signatures. [...]
An announcement from Market Watch claims that Cougar Biotechnology has come to an agreement with the US Food & Drug Administration (FDA) to conduct an additional Phase III trial of abiraterone acetate in prostate cancer. The currently ongoing and much in demand Phase III trial of abiraterone acetate was designed for prostate cancer survivors who [...]
Last Friday's post included information about the recent appointment of Dr. Frank M. Torti as the Acting Director of the FDA. Dr. Torti has invited public comments about the future direction of the FDA. As a representative of Malecare, I have provided specific feedback to Dr. Torti. The following post includes my comments to him. [...]
